Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature. 2023 03; 615(7954):920-924.
View in:
PubMed
subject areas
Antineoplastic Agents
Histone-Lysine N-Methyltransferase
Humans
Leukemia, Myeloid, Acute
Neoplasm, Residual
Prognosis
Protein Binding
Proto-Oncogene Proteins
Remission Induction
authors with profiles
Michael J. Thirman